Stevanato Group S.p.A. Ordinary Shares (STVN)

Frequently Asked Questions About Stevanato Group S.p.A. Ordinary Shares (STVN)

Does Stevanato Group have global operations?

Yes, Stevanato Group has a global presence with manufacturing facilities in various countries, including Italy, the United States, and China. This international footprint enables the company to serve its diverse client base more effectively and engage in local markets where pharmaceutical needs are expanding.

Has Stevanato Group received any awards or recognitions?

Yes, Stevanato Group has been recognized for its commitment to excellence in manufacturing and innovation within the pharmaceutical packaging sector. The company has received various awards for its product quality, sustainability initiatives, and effective customer solutions.

How does Stevanato Group address regulatory compliance?

Stevanato Group places a strong emphasis on regulatory compliance by adhering to the stringent guidelines set forth by regulatory authorities like the FDA and EMA. The company implements comprehensive quality management systems and rigorous testing protocols to ensure that its products meet all necessary regulatory standards.

How does Stevanato Group ensure product quality?

Stevanato Group maintains high product quality through rigorous quality control measures, including the application of advanced testing and validation protocols. The company adheres to international regulatory standards to ensure that its products meet or exceed the requirements for safety and efficacy.

Is Stevanato Group involved in any partnerships or collaborations?

Yes, Stevanato Group collaborates with various pharmaceutical companies and research institutions to develop customized solutions tailored to specific needs. These partnerships enhance innovation, enable the development of new products, and ensure that the company stays ahead of market trends.

What are the growth prospects for Stevanato Group?

Stevanato Group's growth prospects appear strong due to the increasing demand for advanced drug delivery solutions fueled by the pharmaceutical and biotechnology industry's expansion. As new therapies and biologics emerge, the company is well-positioned to meet these demands with its innovative product offerings.

What are the key financial metrics for Stevanato Group?

As of the latest financial disclosures, Stevanato Group has reported consistent revenue growth and a strong market position. Key metrics include revenue figures, profit margins, and market capitalization that demonstrate the company's solid performance and attractiveness in the pharmaceutical packaging sector.

What are the main products of Stevanato Group?

Stevanato Group's main products include glass vials, cartridges, and syringes that are crucial for the containment and delivery of injectable pharmaceuticals. Additionally, they provide integrated services that include design, manufacturing, and quality assurance to ensure product performance and safety for patients.

What does Stevanato Group S.p.A. do?

Stevanato Group S.p.A. is a leading global provider of drug containment and delivery solutions, specializing in the development and manufacturing of glass vials and cartridges used for pharmaceuticals. The company focuses on integrated solutions that enhance the efficiency and safety of drug delivery, ensuring that critical therapies reach patients in a reliable manner.

What industries does Stevanato Group serve?

Stevanato Group serves the pharmaceutical and biotechnology industries, providing innovative solutions for drug packaging and delivery. Their products support a wide array of therapeutic areas, including biologics, vaccines, and complex small molecules, ensuring that essential medications are packaged safely and effectively.

What is Stevanato Group's commitment to sustainability?

Stevanato Group is committed to sustainability through the adoption of environmentally-friendly practices in its manufacturing processes. The company focuses on preserving resources, reducing carbon emissions, and implementing recycling initiatives to minimize waste in the production of its packaging solutions.

What is the corporate culture of Stevanato Group?

Stevanato Group embraces a corporate culture centered around innovation, integrity, and customer focus. The company promotes collaboration and values the contributions of its employees, fostering an environment where creative ideas are encouraged and professionalism is prioritized.

What is the significance of Stevanato Group's public listing?

Stevanato Group went public on the New York Stock Exchange (NYSE) under the ticker symbol STVN in 2021. This significant milestone allows the company to increase its capital, enhance its market visibility, and invest further in research and development to drive innovation and growth.

What kind of employees does Stevanato Group look for?

Stevanato Group seeks employees who are innovative, dedicated, and possess a strong understanding of the pharmaceutical industry. The company values diversity and aims to build teams that bring various perspectives to drive creative solutions and enhance operational excellence.

What role does research and development play in Stevanato Group?

Research and development (R&D) play a critical role in Stevanato Group's operations, driving innovation and maintaining competitiveness in the market. The company invests significantly in R&D to develop new products, improve existing ones, and explore new technologies that can enhance drug delivery solutions.

What technological innovations has Stevanato Group introduced?

Stevanato Group has introduced several technological innovations, including advanced glass-forming processes, automated manufacturing solutions, and integrated drug delivery systems. These innovations work to enhance product performance, streamline production, and ensure the safe delivery of medications.

When was Stevanato Group founded?

Stevanato Group was founded in 1949, originally as a glass manufacturer. Over the decades, the company has evolved considerably, now positioning itself as a key player in the pharmaceutical supply chain with a broad portfolio of products and services.

Where is Stevanato Group headquartered?

Stevanato Group is headquartered in Piombino Dese, Italy. This strategic location allows the company to leverage its rich heritage in glass production while being close to its key customers in the pharmaceutical and biotechnology sectors undergoing rapid growth.

Who are Stevanato Group's main competitors?

Stevanato Group operates in a competitive industry with several key players, including Schott AG, Hoya Corporation, and Gerresheimer AG. These competitors also manufacture pharmaceutical packaging solutions, making the market dynamic and driving continuous innovation.

What is the current price of Stevanato Group S.p.A. Ordinary Shares?

The current price of Stevanato Group S.p.A. Ordinary Shares is 20.97

When was Stevanato Group S.p.A. Ordinary Shares last traded?

The last trade of Stevanato Group S.p.A. Ordinary Shares was at 7:00 pm EDT on April 2nd, 2025